New drug combo aims to protect kidney transplants from early failure
NCT ID NCT06855758
First seen Jun 25, 2026 · Last updated Jul 14, 2026 · Updated 3 times
Summary
This study tests whether adding terlipressin to standard care helps maintain stable blood pressure during kidney transplant surgery. Researchers will compare two groups of 150 adults: one receiving terlipressin plus dobutamine, the other dobutamine alone. The main goal is to see if terlipressin reduces the need for dialysis in the first week after transplant.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- terlipressin
- What this could lead to
- If it works, this could improve blood pressure control during kidney transplant surgery and reduce the need for dialysis shortly after transplant.
- What could go wrong
- This is a small, early-stage trial (150 people) testing a drug already used for other conditions. The benefit may be modest or not confirmed in larger studies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DELAYED GRAFT FUNCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Friendship Hospital
Beijing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which diuretic protects a new kidney best? a Head-to-Head trial puts furosemide and mannitol to the test
- Can a new drug combo help kidney transplants last longer?
- Ultrasound may fine-tune fluid balance in dialysis patients — a trial puts it to the test
- Blood test may take the guesswork out of transplant drug dosing
- Dialysis patients may straighten up with In-Chair exercise
- New nerve block may cut opioid use after kidney transplants